Literature DB >> 20442285

Involvement of the tubulin tyrosine ligase-like family member 4 polyglutamylase in PELP1 polyglutamylation and chromatin remodeling in pancreatic cancer cells.

Kotoe Kashiwaya1, Hidewaki Nakagawa, Masayo Hosokawa, Yasuo Mochizuki, Koji Ueda, Lianhua Piao, Suyoun Chung, Ryuji Hamamoto, Hidetoshi Eguchi, Hiroaki Ohigashi, Osamu Ishikawa, Carsten Janke, Yasuhisa Shinomura, Yusuke Nakamura.   

Abstract

Polyglutamylation is a new class of posttranslational modification in which glutamate side chains are formed in proteins, although its biological significance is not well known. Through our genome-wide gene expression profile analyses of pancreatic ductal adenocarcinoma (PDAC) cells, we identified the overexpression of tubulin tyrosine ligase-like family member 4 (TTLL4) in PDAC cells. Subsequent reverse transcription-PCR and Northern blot analyses confirmed its upregulation in several PDACs. TTLL4 belongs to the TTLL family which was reported to have polyglutamylase activity. Knockdown of TTLL4 by short hairpin RNA in PDAC cells attenuated the growth of PDAC cells and exogenous introduction of TTLL4 enhanced cell growth. We also found that TTLL4 expression was correlated with polyglutamylation levels of a glutamate stretch region of the proline, glutamate, and leucine-rich protein 1 (PELP1) that was shown to interact with various proteins such as histone H3, and was involved in several signaling pathways through its function as a scaffold protein. PELP1 polyglutamylation could influence its interaction with histone H3 and affect histone H3 acetylation. We also identified the interaction of PELP1 with LAS1L and SENP3, components of the MLL1-WDR5 supercomplex involving chromatin remodeling. Our findings imply that TTLL4 could play important roles in pancreatic carcinogenesis through its polyglutamylase activity and subsequent coordination of chromatin remodeling, and might be a good molecular candidate for the development of new therapeutic strategies for pancreatic cancer. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442285     DOI: 10.1158/0008-5472.CAN-09-4444

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

Review 1.  Targeting mitotic pathways for endocrine-related cancer therapeutics.

Authors:  Shivangi Agarwal; Dileep Varma
Journal:  Endocr Relat Cancer       Date:  2017-06-14       Impact factor: 5.678

2.  PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.

Authors:  Yiliao Luo; Mengxing Li; Uday P Pratap; Suryavathi Viswanadhapalli; Junhao Liu; Prabhakar P Venkata; Kristin A Altwegg; Bridgitte E Palacios; Xiaonan Li; Yihong Chen; Manjeet K Rao; Andrew J Brenner; Gangadhara R Sareddy; Ratna K Vadlamudi
Journal:  Mol Carcinog       Date:  2019-12-24       Impact factor: 4.784

Review 3.  The chemical complexity of cellular microtubules: tubulin post-translational modification enzymes and their roles in tuning microtubule functions.

Authors:  Christopher P Garnham; Antonina Roll-Mecak
Journal:  Cytoskeleton (Hoboken)       Date:  2012-04-26

4.  The histone variant MacroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1.

Authors:  Kristine M Hussey; Hongshan Chen; Christine Yang; Eugene Park; Nasun Hah; Hediye Erdjument-Bromage; Paul Tempst; Matthew J Gamble; W Lee Kraus
Journal:  Mol Cell Biol       Date:  2014-04-21       Impact factor: 4.272

5.  Effects of aging on apoptosis gene expression in oral mucosal tissues.

Authors:  Octavio A Gonzalez; M John Novak; Sreenatha Kirakodu; Arnold J Stromberg; Shu Shen; Luis Orraca; Janis Gonzalez-Martinez; Jeffrey L Ebersole
Journal:  Apoptosis       Date:  2013-03       Impact factor: 4.677

6.  Phosphinic acid-based inhibitors of tubulin polyglutamylases.

Authors:  Yanjie Liu; Christopher P Garnham; Antonina Roll-Mecak; Martin E Tanner
Journal:  Bioorg Med Chem Lett       Date:  2013-05-30       Impact factor: 2.823

Review 7.  PELP1: Structure, biological function and clinical significance.

Authors:  Gangadhara Reddy Sareddy; Ratna K Vadlamudi
Journal:  Gene       Date:  2016-03-18       Impact factor: 3.688

8.  Disruption of Ttll5/stamp gene (tubulin tyrosine ligase-like protein 5/SRC-1 and TIF2-associated modulatory protein gene) in male mice causes sperm malformation and infertility.

Authors:  Geun-Shik Lee; Yuanzheng He; Edward J Dougherty; Maria Jimenez-Movilla; Matteo Avella; Sean Grullon; David S Sharlin; Chunhua Guo; John A Blackford; Smita Awasthi; Zhenhuan Zhang; Stephen P Armstrong; Edra C London; Weiping Chen; Jurrien Dean; S Stoney Simons
Journal:  J Biol Chem       Date:  2013-04-04       Impact factor: 5.157

Review 9.  PELP1: a review of PELP1 interactions, signaling, and biology.

Authors:  Brian J Girard; Andrea R Daniel; Carol A Lange; Julie H Ostrander
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

10.  TTLL12 expression in ovarian cancer correlates with a poor outcome.

Authors:  Shangjie Yang; Yanping Liang; Haihong Qian; Qiuhong Li
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.